SOLLINI, MARTINA
 Distribuzione geografica
Continente #
AS - Asia 2.573
EU - Europa 2.268
NA - Nord America 1.781
SA - Sud America 415
AF - Africa 79
OC - Oceania 26
Totale 7.142
Nazione #
US - Stati Uniti d'America 1.680
RU - Federazione Russa 1.182
SG - Singapore 983
CN - Cina 746
IT - Italia 583
BR - Brasile 350
HK - Hong Kong 303
VN - Vietnam 156
BD - Bangladesh 151
FR - Francia 97
DE - Germania 89
GB - Regno Unito 81
NL - Olanda 69
FI - Finlandia 53
IN - India 53
CA - Canada 52
MX - Messico 42
AU - Australia 24
PL - Polonia 24
AR - Argentina 23
JP - Giappone 23
MA - Marocco 23
AT - Austria 22
ZA - Sudafrica 21
PK - Pakistan 17
TR - Turchia 17
ES - Italia 16
SA - Arabia Saudita 13
MY - Malesia 12
TH - Thailandia 12
LT - Lituania 11
DZ - Algeria 10
EG - Egitto 10
ID - Indonesia 10
IQ - Iraq 10
SE - Svezia 10
CO - Colombia 9
EC - Ecuador 9
PH - Filippine 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
UZ - Uzbekistan 7
VE - Venezuela 7
PY - Paraguay 6
BE - Belgio 5
KR - Corea 5
TN - Tunisia 5
BO - Bolivia 4
CL - Cile 4
IL - Israele 4
MD - Moldavia 4
NP - Nepal 4
UA - Ucraina 4
BA - Bosnia-Erzegovina 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
OM - Oman 3
UY - Uruguay 3
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
LK - Sri Lanka 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
NI - Nicaragua 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 7.142
Città #
Singapore 520
San Jose 302
Ashburn 300
Hong Kong 296
Moscow 260
Dallas 169
Beijing 153
Shanghai 141
Milan 139
New York 107
Hefei 105
Lauterbourg 81
Los Angeles 60
Rome 56
Ho Chi Minh City 50
Council Bluffs 40
Hanoi 40
Santa Clara 34
Seattle 32
Boardman 30
São Paulo 29
Helsinki 26
Nuremberg 23
Denver 21
Amsterdam 20
Chennai 20
London 19
Montreal 19
Orem 19
The Dalles 19
Brooklyn 18
Mexico City 17
Turku 17
Warsaw 17
Washington 17
Brescia 16
Munich 16
Tokyo 16
Naples 15
Canberra 14
Johannesburg 14
Florence 13
Poplar 13
Atlanta 12
Buffalo 12
Cesano Boscone 12
Rio de Janeiro 12
Houston 11
Manchester 11
Shenzhen 11
Ankara 10
Bang Kruai 10
Lappeenranta 10
Memphis 10
Phoenix 10
Bologna 9
Toronto 9
Turin 9
Belo Horizonte 8
Da Nang 8
Frankfurt am Main 8
Guangzhou 8
Bari 7
Charlotte 7
Chicago 7
Curitiba 7
Falkenstein 7
Hangzhou 7
Mumbai 7
Rabat 7
San Francisco 7
Sydney 7
Vienna 7
Assago 6
Catania 6
City of London 6
Genoa 6
Haiphong 6
Lahore 6
Las Vegas 6
Pisa 6
Querétaro 6
Riyadh 6
Stockholm 6
Vancouver 6
Macerata 5
Salvador 5
Secaucus 5
Suzhou 5
Tashkent 5
Aracaju 4
Biên Hòa 4
Boston 4
Brasília 4
Cape Town 4
Carapicuíba 4
Casablanca 4
Chongqing 4
Contagem 4
Córdoba 4
Totale 3.737
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 246
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 187
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 145
Cardiac molecular pathways influenced by doxorubicin treatment in mice 136
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 132
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 119
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 116
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 115
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 115
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 114
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 114
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 113
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 111
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 105
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 103
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 101
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 100
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 100
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 99
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 96
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 94
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 93
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 92
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 91
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 89
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 89
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 86
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 85
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 85
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 82
Perceived risk and decision-making: navigating uncertainty in clinical practice 75
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 75
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 73
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 73
On the Automation of Radiomics-based Identification and Characterization of NSCLC 72
Alternative Nuclear Imaging Tools for Infection Imaging 72
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 72
Radiomics of Liver Metastases: A Systematic Review 71
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 71
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 70
FAP expression in alpha cells of Langherhans insulae-implications for FAPI radiopharmaceuticals' use 70
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 68
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 67
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 67
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 66
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 66
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 65
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 65
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 64
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 64
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 64
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 63
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 63
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 62
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 61
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 61
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 60
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 60
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 60
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 58
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 56
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 56
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 56
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 55
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 55
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 55
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 54
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges 54
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 54
PET/CT radiomics in breast cancer: Mind the step 54
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 54
Methodological framework for radiomics applications in Hodgkin’s lymphoma 53
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers 53
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 53
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 53
From pixels to predictions: the scrying power of molecular imaging 51
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer 51
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 51
Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT 50
Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance 50
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 50
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 50
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 49
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 49
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 49
Mapping Tumor Heterogeneity via Local Entropy Assessment: Making Biomarkers Visible 49
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging 49
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 49
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 48
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification 47
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach 46
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 45
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 45
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 44
Dual adversarial deconfounding autoencoder for joint batch-effects removal from multi-center and multi-scanner radiomics data 44
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 42
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 42
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective Cohort 41
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 40
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 40
Totale 7.337
Categoria #
all - tutte 35.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023138 6 0 1 0 0 1 0 0 2 10 116 2
2023/2024717 8 145 82 45 56 69 33 85 41 35 31 87
2024/20251.548 157 53 21 59 80 143 177 158 305 194 114 87
2025/20265.046 382 352 198 620 449 168 620 322 1.122 296 248 269
Totale 7.450